Hussman Strategic Advisors, Inc. Eagle Pharmaceuticals, Inc. Transaction History

Hussman Strategic Advisors, Inc.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2019 May 01, 2019	SELL	$38.66 - $51.82 $966,499 - $1.3 Million	-25,000 Closed	0 $0
Q3 2018 Oct 31, 2018	BUY	$66.65 - $83.86 $1.67 Million - $2.1 Million	25,000 New	25,000 $1.73 Million

8.6M

100

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $7.81M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

Get notified when there are updates to the investment portfolio of Hussman Strategic Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Hussman Strategic Advisors, Inc. with notifications on news.